Satellite Banner
Technology Networks Header
Friday, August 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

Tecan Launches New Options for Cavro® Omni Robot
Wednesday, July 16, 2014
Cavro Omni Robot Version 4.0 launched at the AACC’s 2014 Clinical Lab Expo.

Binding Site Chosen as Partner in the Black Swan ‘Cure Myeloma’ Research Initiative
Wednesday, July 16, 2014
Freelite® and Hevylite® will help the Black Swan Research Initiative® find the best treatment to cure multiple myeloma.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

New Magnetic Technology for Bioseparations and Studies of Biomolecular Interactions
Tuesday, July 15, 2014
AMSBIO announces MagSi-Direct - a revolutionary technology that brings the power, simplicity, and convenience of magnetic separation.

Faster Diagnosis of HSV in the Immunocompromised
Thursday, July 10, 2014
New Iam HSV provides rapid molecular confirmation of HSV infection in immunocompromised individuals and in cases of herpes simplex encephalitis.

SciGene Introduces Dual Temperature FISH Slide Incubator
Tuesday, July 01, 2014
CytoBrite Duo Slide Incubation system for performing FISH hybridization protocols.

LifeCodexx Expands its PraenaTest® Spectrum
Saturday, June 28, 2014
Additional PraenaTest® options for the exclusive determination of fetal trisomy 21 and gonosomal aneuploidy now available.

Randox Launches New Ammonia Ethanol EQA Programme On RIQAS
Thursday, June 26, 2014
A new Randox External Quality Assurance (EQA) programme monitoring Ammonia and Ethanol will be available on RIQAS from September 2014.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 446
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv